H. Fang

[Safety and immunogenicity of split vaccines of influenza viruses].

Chang-lin Zhu, H. Fang, F. Zhu, Yu-qi Wang +4 more

2004Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology1 citations

Semantic Scholar

H. Fang

Most-cited papers

A novel influenza A (H1N1) vaccine in various age groups.

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

A Novel Influenza A ( H 1 N 1 ) Vaccine in Various Age Groups

Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China.

A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial.

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.

Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine.

Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China.

[Effectiveness of inactivated poliomyelitis vaccine for primary vaccination].

Adverse reaction and immunogenicity induced by freeze-dried live attenuated varicella vaccine.

[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China].

[Evaluation on the safety and immunogenicity of Canada split influenza virus vaccine].

[Safety and immunogenicity of split vaccines of influenza viruses].

中国婴幼儿接种吸附无细胞百白破灭活脊髓灰质炎和b 型流感嗜血杆菌（结合）联合疫苗的安全性和免疫原性研究

Geometric mean titre ratios (Day22:Day1) in all subjects in the Phase II/III trial

[Analysis and evaluation on quality of live attenuated measles vaccine from market surveillance sampling].

大流行流感疫苗毒种(NIBRG-14)的传代稳定性

麻疹、腮腺炎、风疹三联减毒活疫苗的安全性和免疫原性研究

[Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].

[Analysis of influenza antibodies in normal people in Jiangsu Province in 2003 ].

[Study on the immunization effect of measles vaccine by capture-EIA].